Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Mitigating Pain Following Refractive Surgery
This study is currently recruiting participants.
Verified by FORSIGHT Vision3, August 2008
Sponsored by: FORSIGHT Vision3
Information provided by: FORSIGHT Vision3
ClinicalTrials.gov Identifier: NCT00691925
  Purpose

Using Contact lens following refractive procedure to reduce pain.


Condition
Pain

MedlinePlus related topics: Eye Wear
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Contact Lens for Mitigating Pain Following Refractive Procedure

Further study details as provided by FORSIGHT Vision3:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 10
Study Start Date: June 2008
Estimated Study Completion Date: August 2008
Estimated Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
bilateral post refractive surgery subject

Detailed Description:

Patients at day 1 following the procedure will be treated with a contact lens and assessed for pain at 1,2,4 hours and 1,3,5 days.

prospective comparative study

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

at least 10 subjects following refractive surgery

Criteria

Inclusion Criteria:

  1. Patients who underwent bilateral Refractive surgery for myopic correction.
  2. Age 18-60.
  3. Evidence of an epithelial defect.
  4. Patient complains of significant pain.
  5. Patients able to understand the requirements of the study and willing to follow study instructions, to provide written informed consent to participate, and who agree to comply with all study requirements, including the required study follow-up visits.

Exclusion Criteria:

  1. Any other anterior segment abnormality other than that associated with Refractive surgery.
  2. Any abnormalities associated with the eye lids.
  3. Prior laser treatment of the retina.
  4. Any ophthalmic surgery performed within three (3) months prior to study excluding Refractive surgery.
  5. Diagnosis of glaucoma.
  6. Active diabetic retinopathy.
  7. Clinically significant inflammation or infection within six (6) months prior to study.
  8. Uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of the Investigator.
  9. Participation in any study involving an investigational drug within the past 30 calendar days, or ongoing participation in a study with an investigational material.
  10. Intolerance or hypersensitivity to topical anesthetics,
  11. Specifically known intolerance or hypersensitivity to contact lenses.
  12. A medical condition, serious intercurrent illness, or extenuating circumstance that would significantly decrease study compliance, including all prescribed follow-up.
  13. Any condition that, in the opinion of the investigator, would jeopardize the safety of the patient.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00691925

Contacts
Contact: Osnat Ehrman, MSc 952-334-5797 osnat.ehrman@gmail.com

Locations
Israel
Sorasky Medical Center Recruiting
Tel Aviv, Israel
Contact: David Verssano, MD            
Principal Investigator: David Verssano, MD            
Sub-Investigator: Moshe Lazar, MD            
Sub-Investigator: Yossi Yatziv, MD            
Sponsors and Collaborators
FORSIGHT Vision3
Investigators
Principal Investigator: David Verssano, MD Sorasky Medical Center
  More Information

Responsible Party: FORSIGHT ( Osnat Ehrman )
Study ID Numbers: 0164
Study First Received: June 4, 2008
Last Updated: August 22, 2008
ClinicalTrials.gov Identifier: NCT00691925  
Health Authority: Israel: Ministry of Health

Keywords provided by FORSIGHT Vision3:
refractive surgery

Study placed in the following topic categories:
Pain

ClinicalTrials.gov processed this record on January 15, 2009